(Press-News.org) A recent study from the University of Eastern Finland in collaboration with Deakin University, Australia, shows that recurrent major depressive disorder (MDD) in men is associated with lower bone density. The use of antidepressants was also associated with lower bone mineral density (BMD), but this association was dependent on the person's weight and site of bone measurement.
Osteoporosis is a common disorder and an underlying factor in fragility fractures. Especially in women, the menopause increases the risk of osteoporosis. Other risk factors include low levels of physical activity, smoking, low intake of calcium and vitamin D, as well as some medications and diseases. In the elderly, susceptibility to fracture and serious hip fractures can result in long-term hospitalization and decreased state of health.
Previous studies have shown that also depression is associated with lower bone density. This might be due to the effects of depression-induced long-term stress and increased secretion of inflammatory markers. Furthermore, selective serotonin reuptake inhibitors (SSRIs) used to treat depression have been shown to weaken bone health. However, the majority of studies has focused on postmenopausal women. The present study analysed the association of single and recurrent MDD episodes and the use of antidepressants with bone density in men.
The study analysed data from the Geelong Osteoporosis Study, GOS, which is a large, ongoing, population-based osteoporosis study carried out in the Barwon Health hospital district in Australia. Between 2006 and 2011, 928 men (aged 24-98 years) completed a comprehensive questionnaire and had BMD assessments at the forearm, spine, total hip and total body. MDD was identified using a structured clinical interview. Multivariate model was adjusted for lifestyle, medications and other confounding factors.
Nine per cent of the study population had had a single MDD episode, and five per cent had suffered from recurrent MDD. Furthermore, seven per cent of the study participants reported the use of antidepressants at the time of assessment.
Recurrent MDD was associated with lower BMD at the forearm and total body (-6.5% and -2.5%, respectively compared to men with no history of MDD), while single MDD episodes were associated with higher BMD at the total hip (+3.4%).
Antidepressant use was associated with lower BMD only in lower-weight men and varied across the bone sites. For example, the use of antidepressants was associated with reduced bone density in the hip in men weighing less than 110 kilograms. In the forearm, however, the association of anti-depressants with reduced bone density was not observed in men until their body weight was under 75 kilograms.
According to the study, recurrent major depression may increase the risk of osteoporosis in men. Furthermore, the use of antidepressants should be taken into account as a potential risk factor of osteoporosis especially in men with a low body weight.
The study constitutes part of the PhD project of Researcher Päivi Rauma, focusing on the effects of depression and antidepressants on bone health. The findings were published in Journal of Musculoskeletal and Neuronal Interactions.
INFORMATION:
For further information, please contact: Päivi Rauma, University of Eastern Finland, School of Pharmacy/ Social Pharmacy & Clinical Research Centre/ Bone and Cartilage Research Unit, tel. +358 40 842 5823, prauma@student.uef.fi
Research article:
The association between major depressive disorder, use of antidepressants and bone mineral density (BMD) in men. P.H. Rauma, J.A. Pasco, M. Berk, A.L. Stuart, H. Koivumaa-Honkanen, R.J. Honkanen, J.M Hodge, L.J. Williams. J Musculoskelet Neuronal Interact 2015; 15(2):177-185.
http://www.ismni.org/jmni/pdf/60/08RAUMA.pdf
The team headed by Dr. Kathrin Suttner, who, together with Prof. Dr. Carsten Schmidt-Weber, heads the airway immunology research group at the Helmholtz Zentrum München and Technische Universität München, concentrated its work on the so-called naive CD4+ T cells. They are a precursor form of T cells and form the basis for immunological memory*. Impaired development of these cells can influence the entire immune system and lead to illnesses such as allergies and asthma.
Protein atlas on T cell precursors
The scientists specifically examined proteins on ...
Clinicians at Ludwig-Maximilians-Universitaet (LMU) in Munich have elucidated a mechanism involved in determining the lifespan of antibody-producing cells, and identified a promising new biomarker for monitoring autoimmune diseases like multiple sclerosis and lupus erythematosus.
The so-called humoral immune response is mediated by plasma cells and plays a central role in combating infections. Plasma cells secrete antibodies - a class of proteins that specifically recognize infectious pathogens and facilitate their destruction. Individual plasma cells make only a single ...
Rome, Italy, 12 June 2015: The results of a systematic review of published studies presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) Press Conference showed that biologics improve both absenteeism (not showing up for work) and presenteeism (being at work but not functioning fully) in patients with chronic inflammatory arthritides. Rheumatic conditions are the most frequently cited reason for absence from work, and these findings suggest that biologics could significantly reduce the economic burden of these diseases.
Chronic inflammatory ...
Rome, Italy, 12 June 2015: The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) Press Conference showed that people with rheumatoid arthritis (RA) are less likely to be protected by hepatitis B vaccination than the general population. Within the trial only 11% of those with the condition responded to the vaccine, compared with 83% of those without RA, suggesting that people with RA may still be at risk of infection in spite of vaccination.
"The majority of RA patients tested as part of our study were not protected ...
Rome, Italy, 12 June 2015: The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) showed that inspiratory muscle training (IMT) significantly improves lung strength and efficiency in patients with ankylosing spondylitis (AS), a condition often associated with breathing difficulties. These findings demonstrate that just eight weeks of IMT provide greater improvements in lung function than conventional treatment options.
AS is a painful and progressive form of arthritis caused by chronic inflammation of the joints ...
Rome, Italy, 12 June 2015: The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) demonstrated for the first time that treatment-naive patients with early Rheumatoid Arthritis (RA) have myocardial and vascular abnormalities, even at the earliest stage of their disease. These findings suggest that patients may develop early cardiomyopathy (disease of the heart muscle), increasing their risk of cardiovascular morbidity and mortality from the time of their diagnosis. Cardiomyopathy is a serious condition and a leading ...
Rome, Italy, 12 June 2015: The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) identified that the cytokine (cell signalling protein) Interleukin-1β (IL-1β) is a crucial factor in the development of blood-induced cartilage damage. This finding opens up the possibility that a treatment targeting IL-1β could provide a new way to protect cartilage after a joint bleed, which in turn should significantly reduce subsequent disability.1
Exposure of joint cartilage to blood can occur after joint trauma, ...
Rome, Italy, 12 June 2015: Two new studies presented at the European League Against Rheumatism Annual Congress (EULAR 2015) have shown the importance of using ultrasound to identify those Rheumatoid Arthritis (RA) patients in clinical remission who would benefit from more intensive treatment.
Many patients deemed to be in clinical remission still have active joint disease without any obvious symptoms or physical signs, but with risk of further progression of joint damage. Using ultrasound to predict the risk of flare and exacerbation of symptoms will allow these patients ...
Rome, Italy, 12 June 2015: The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) Press Conference showed that the chickenpox (varicella) vaccine can be effective and safe even in children with paediatric rheumatic disease receiving immunosuppression treatment. By using a checklist to pre-screen children, the investigators were able to identify diverse patient groups suitable for vaccination, protecting them from a potentially life-threatening infection.
Rheumatic diseases are autoimmune diseases, arising when the ...
Rome, Italy, 12 June 2015: Three new studies presented at the European League Against Rheumatism Annual Congress (EULAR 2015) have provided valuable guidance on measuring fatigue and optimising its treatment in Rheumatoid Arthritis (RA) patients, and in patients with other rheumatic diseases. Fatigue remains a frequent and debilitating problem for patients with RA that needs to be addressed.
Findings from these studies show:
Chronic fatigue in RA patients has been identified as not being well managed by healthcare professionals, with 79% claiming their fatigue had ...
